The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
Healthcare remains in inadequate supply throughout most of the SEA region. The shortage is especially evident in healthcare human resources; for instance, apart from Malaysia and China, all the countries in the SEA region have fewer than 1 physician ...
View more details
Malaysia has one of the most developed pharmaceuticals and healthcare sectors in the ASEAN region. The country operates a dual public-private healthcare system in which the government, under the Ministry of Health (“MoH”), both regulates ...
View more details
With 1.4bn population each as of 2017, India and China are the most numerous countries out of the six forming the focus of this report. However, the two countries differ widely in terms of per capita GDP, with that of China being more than twice that ...
View more details
Demand in the Malaysian Pharmaceuticals & Healthcare sector has been growing rapidly over the last few years as Malaysians have become more affluent and demanding with their healthcare needs. The aging population has also been seeing higher ...
View more details
The Malaysian healthcare and pharmaceuticals sector has been growing strongly as a result of factors including one of the highest population growth rates in the ASEAN region, increasing affluence, and growing access to healthcare funding. In ...
View more details